Project acronym CELLTYPESANDCIRCUITS
Project Neural circuit function in the retina of mice and humans
Researcher (PI) Botond Roska
Host Institution (HI) FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH FONDATION
Call Details Starting Grant (StG), LS5, ERC-2010-StG_20091118
Summary The mammalian brain is assembled from thousands of neuronal cell types that are organized into distinct circuits to perform behaviourally relevant computations. To gain mechanistic insights about brain function and to treat specific diseases of the nervous system it is crucial to understand what these local circuits are computing and how they achieve these computations. By examining the structure and function of a few genetically identified and experimentally accessible neural circuits we plan to address fundamental questions about the functional architecture of neural circuits. First, are cell types assigned to a unique functional circuit with a well-defined function or do they participate in multiple circuits (multitasking cell types), adjusting their role depending on the state of these circuits? Second, does a neural circuit perform a single computation or depending on the information content of its inputs can it carry out radically different functions? Third, how, among the large number of other cell types, do the cells belonging to the same functional circuit connect together during development? We use the mouse retina as a model system to address these questions. Finally, we will study the structure and function of a specialised neural circuit in the human fovea that enables humans to read. We predict that our insights into the mechanism of multitasking, network switches and the development of selective connectivity will be instructive to study similar phenomena in other brain circuits. Knowledge of the structure and function of the human fovea will open up new opportunities to correlate human retinal function with human visual behaviour and our genetic technologies to study human foveal function will allow us and others to design better strategies for restoring vision for the blind.
Summary
The mammalian brain is assembled from thousands of neuronal cell types that are organized into distinct circuits to perform behaviourally relevant computations. To gain mechanistic insights about brain function and to treat specific diseases of the nervous system it is crucial to understand what these local circuits are computing and how they achieve these computations. By examining the structure and function of a few genetically identified and experimentally accessible neural circuits we plan to address fundamental questions about the functional architecture of neural circuits. First, are cell types assigned to a unique functional circuit with a well-defined function or do they participate in multiple circuits (multitasking cell types), adjusting their role depending on the state of these circuits? Second, does a neural circuit perform a single computation or depending on the information content of its inputs can it carry out radically different functions? Third, how, among the large number of other cell types, do the cells belonging to the same functional circuit connect together during development? We use the mouse retina as a model system to address these questions. Finally, we will study the structure and function of a specialised neural circuit in the human fovea that enables humans to read. We predict that our insights into the mechanism of multitasking, network switches and the development of selective connectivity will be instructive to study similar phenomena in other brain circuits. Knowledge of the structure and function of the human fovea will open up new opportunities to correlate human retinal function with human visual behaviour and our genetic technologies to study human foveal function will allow us and others to design better strategies for restoring vision for the blind.
Max ERC Funding
1 499 000 €
Duration
Start date: 2010-11-01, End date: 2015-10-31
Project acronym COMPUSLANG
Project Neural and computational determinants of left cerebral dominance in speech and language
Researcher (PI) Anne-Lise Mamessier
Host Institution (HI) UNIVERSITE DE GENEVE
Call Details Starting Grant (StG), LS5, ERC-2010-StG_20091118
Summary More than a century after Wernicke and Broca established that speech perception and production rely on temporal and prefrontal cortices of the left brain hemisphere, the biological determinants for this organization are still unknown. While functional neuroanatomy has been described in great detail, the neuroscience of language still lacks a physiologically plausible model of the neuro-computational mechanisms for coding and decoding of speech acoustic signal. We propose to fill this gap by testing the biological validity and exploring the computational implications of one promising proposal, the Asymmetric Sampling in Time theory. AST assumes that speech signals are analysed in parallel at multiple timescales and that these timescales differ between left and right cerebral hemispheres. This theory is original and provocative as it implies that a single computational difference, distinct integration windows in right and left auditory cortices could be sufficient to explain why speech is preferentially processed by the left brain, and possible even why the human brain has evolved toward such an asymmetric functional organization. Our proposal has four goals: 1/ to validate, invalidate or amend AST on the basis of physiological experiments in healthy human subjects including functional magnetic resonance imaging (fMRI), combined electroencephalography (EEG) and fMRI, magnetoencephalography (MEG) and subdural electrocorticography (EcoG), 2/ to use computational modeling to probe those aspects of the theory that currently remain inaccessible to empirical testing (evaluation, assessment), 3/ to apply AST to binaural artificial hearing with cochlear implants, 4/ to test for disorders of auditory sampling in autism and dyslexia, two language neurodevelopmental pathologies in which a genetic basis implicates the physiological underpinnings of AST, and 5/ to assess potential generalisation of AST to linguistic action in the context of speech production.
Summary
More than a century after Wernicke and Broca established that speech perception and production rely on temporal and prefrontal cortices of the left brain hemisphere, the biological determinants for this organization are still unknown. While functional neuroanatomy has been described in great detail, the neuroscience of language still lacks a physiologically plausible model of the neuro-computational mechanisms for coding and decoding of speech acoustic signal. We propose to fill this gap by testing the biological validity and exploring the computational implications of one promising proposal, the Asymmetric Sampling in Time theory. AST assumes that speech signals are analysed in parallel at multiple timescales and that these timescales differ between left and right cerebral hemispheres. This theory is original and provocative as it implies that a single computational difference, distinct integration windows in right and left auditory cortices could be sufficient to explain why speech is preferentially processed by the left brain, and possible even why the human brain has evolved toward such an asymmetric functional organization. Our proposal has four goals: 1/ to validate, invalidate or amend AST on the basis of physiological experiments in healthy human subjects including functional magnetic resonance imaging (fMRI), combined electroencephalography (EEG) and fMRI, magnetoencephalography (MEG) and subdural electrocorticography (EcoG), 2/ to use computational modeling to probe those aspects of the theory that currently remain inaccessible to empirical testing (evaluation, assessment), 3/ to apply AST to binaural artificial hearing with cochlear implants, 4/ to test for disorders of auditory sampling in autism and dyslexia, two language neurodevelopmental pathologies in which a genetic basis implicates the physiological underpinnings of AST, and 5/ to assess potential generalisation of AST to linguistic action in the context of speech production.
Max ERC Funding
1 500 000 €
Duration
Start date: 2011-02-01, End date: 2016-01-31
Project acronym CTLANDROS
Project Reactive Oxygen Species in CTL-mediated Cell Death: from Mechanism to Applications
Researcher (PI) Denis Martinvalet
Host Institution (HI) UNIVERSITE DE GENEVE
Call Details Starting Grant (StG), LS6, ERC-2010-StG_20091118
Summary Cytotoxic T lymphocytes (CTL) and natural killer (NK) cells release granzyme and perforin from cytotoxic granules into the immune synapse to induce apoptosis of target cells that are either virus-infected or cancerous. Granzyme A activates a caspase-independent apoptotic pathway and induces mitochondrial damage characterized by superoxide anion production and loss of the mitochondrial transmembrane potential, without disrupting the integrity of the mitochondrial outer membrane; while causing single-stranded DNA damage. GzmB induces both caspase-dependent and caspase-independent cell death. In the caspase-dependent pathway, mitochondrial functions are altered as evidenced by the loss of mitochondrial transmembrane potential and the generation of reactive oxygen species (ROS). The mitochondrial outer membrane (MOM) is disrupted, resulting in the release of apoptogenic factors. To date, research on mitochondrial-dependent apoptosis has focused on mitochondrial outer membrane permeabilization (MOMP) however whether the generation of ROS is incidental or essential to the execution of apoptosis remains unclear. Like human GzmA, human GzmB promotes cell death in a ROS-dependent manner. Preliminary data suggest that human GzmB can induce ROS in a MOMP-independent manner as Bax and Bak double knockout MEF cells treated with human GzmB and perforin still display a robust ROS production and dye in an ROS-dependent manner. Since GzmA and GzmB induce cell death in a ROS-dependent manner, we hypothesize that oxygen free radicals are central to the execution of programmed cell death induced by the cytotoxic granules. Therefore, the goal of this proposal is to dissect the key molecular events triggered by ROS that lead to Citotoxic Tcell-induced target cell death. A combination of biochemical, genetic and proteomic approaches in association with Electron Spin Resonance (ESR) spectroscopy methodology will be used to unravel the essential role ROS play in CTL-mediated killing.
Summary
Cytotoxic T lymphocytes (CTL) and natural killer (NK) cells release granzyme and perforin from cytotoxic granules into the immune synapse to induce apoptosis of target cells that are either virus-infected or cancerous. Granzyme A activates a caspase-independent apoptotic pathway and induces mitochondrial damage characterized by superoxide anion production and loss of the mitochondrial transmembrane potential, without disrupting the integrity of the mitochondrial outer membrane; while causing single-stranded DNA damage. GzmB induces both caspase-dependent and caspase-independent cell death. In the caspase-dependent pathway, mitochondrial functions are altered as evidenced by the loss of mitochondrial transmembrane potential and the generation of reactive oxygen species (ROS). The mitochondrial outer membrane (MOM) is disrupted, resulting in the release of apoptogenic factors. To date, research on mitochondrial-dependent apoptosis has focused on mitochondrial outer membrane permeabilization (MOMP) however whether the generation of ROS is incidental or essential to the execution of apoptosis remains unclear. Like human GzmA, human GzmB promotes cell death in a ROS-dependent manner. Preliminary data suggest that human GzmB can induce ROS in a MOMP-independent manner as Bax and Bak double knockout MEF cells treated with human GzmB and perforin still display a robust ROS production and dye in an ROS-dependent manner. Since GzmA and GzmB induce cell death in a ROS-dependent manner, we hypothesize that oxygen free radicals are central to the execution of programmed cell death induced by the cytotoxic granules. Therefore, the goal of this proposal is to dissect the key molecular events triggered by ROS that lead to Citotoxic Tcell-induced target cell death. A combination of biochemical, genetic and proteomic approaches in association with Electron Spin Resonance (ESR) spectroscopy methodology will be used to unravel the essential role ROS play in CTL-mediated killing.
Max ERC Funding
1 500 000 €
Duration
Start date: 2011-05-01, End date: 2016-04-30
Project acronym DNA-AMP
Project DNA Adduct Molecular Probes: Elucidating the Diet-Cancer Connection at Chemical Resolution
Researcher (PI) Shana Jocette Sturla
Host Institution (HI) EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH
Call Details Starting Grant (StG), LS7, ERC-2010-StG_20091118
Summary Bulky DNA adducts formed from chemical carcinogens dictate structure, reactivity, and mechanism of chemical-biological reactions; therefore, their identification is central to evaluating and mitigating cancer risk. Natural food components, or others associated with certain food preparations or metabolic conversions, initiate potentially damaging genetic mutations after forming DNA adducts, which contribute critically to carcinogenesis, despite the fact that they are typically repaired biochemically and they are formed at extremely low levels. This situation places significant limitations on our ability to understand the role of formation, repair, and mutagenesis on the basis of the complex DNA reactivity profiles of food components. The long-term goals of this research are to contribute basic knowledge and advanced experimental tools required to understand, on the basis of chemical structure, the contributions of chronic, potentially adverse, dietary chemical carcinogen exposure to cancer development. It is proposed that a new class of synthetic nucleosides, devised on the basis of preliminary discoveries made in the independent laboratory of the applicant, will serve as molecular probes for bulky DNA adducts and can be effectively used to study and AMPlify, i.e. as a sensitive diagnostic tool, low levels of chemically-specific modes of DNA damage. The proposed research is a chemical biology-based approach to the study of carcinogenesis. Experiments involve chemical synthesis, thermodynamic and kinetic characterization DNA-DNA and enzyme-DNA interactions, and nanoparticle-based molecular probes. The proposal describes a potentially ground-breaking approach for profiling the biological reactivities of chemical carcinogens, and we expect to gain fundamental knowledge and chemical tools that can contribute to the prevention of diseases influenced by gene-environment interactions.
Summary
Bulky DNA adducts formed from chemical carcinogens dictate structure, reactivity, and mechanism of chemical-biological reactions; therefore, their identification is central to evaluating and mitigating cancer risk. Natural food components, or others associated with certain food preparations or metabolic conversions, initiate potentially damaging genetic mutations after forming DNA adducts, which contribute critically to carcinogenesis, despite the fact that they are typically repaired biochemically and they are formed at extremely low levels. This situation places significant limitations on our ability to understand the role of formation, repair, and mutagenesis on the basis of the complex DNA reactivity profiles of food components. The long-term goals of this research are to contribute basic knowledge and advanced experimental tools required to understand, on the basis of chemical structure, the contributions of chronic, potentially adverse, dietary chemical carcinogen exposure to cancer development. It is proposed that a new class of synthetic nucleosides, devised on the basis of preliminary discoveries made in the independent laboratory of the applicant, will serve as molecular probes for bulky DNA adducts and can be effectively used to study and AMPlify, i.e. as a sensitive diagnostic tool, low levels of chemically-specific modes of DNA damage. The proposed research is a chemical biology-based approach to the study of carcinogenesis. Experiments involve chemical synthesis, thermodynamic and kinetic characterization DNA-DNA and enzyme-DNA interactions, and nanoparticle-based molecular probes. The proposal describes a potentially ground-breaking approach for profiling the biological reactivities of chemical carcinogens, and we expect to gain fundamental knowledge and chemical tools that can contribute to the prevention of diseases influenced by gene-environment interactions.
Max ERC Funding
1 500 000 €
Duration
Start date: 2010-09-01, End date: 2015-08-31
Project acronym DYNACLOCK
Project Dynamic protein-DNA interactomes and circadian transcription regulatory networks in mammals
Researcher (PI) Felix Naef
Host Institution (HI) ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
Call Details Starting Grant (StG), LS2, ERC-2010-StG_20091118
Summary The aim of this project is to understand the dynamics of protein-DNA interactomes underlying circadian oscillators in mammals, and how these shape circadian transcriptional output programs. Specifically our goal is to solve a fundamental issue in circadian biology: the phase specificity problem underlying circadian gene expression. We have taken a challenging and original multi-disciplinary approach in which molecular biology experiments will be tightly interlinked with computational analyses and biophysical modeling. The approach will generate time resolved protein-DNA interactomes in mouse liver for several key circadian repressors at unprecedented resolution. These experiments will be complemented with chromosome conformation capture (3C) experiments to monitor how looping interactions and 3D genome structure rearrange during the circadian cycle, which will inform on how circadian transcription networks use long-range gene regulatory mechanisms. Novel computational algorithms based on biophysical principles will be developed and implemented to optimally analyze interactome and 3C datasets. For the latter, statistical models from polymer physics will be used to reconstruct the chromatin networks and interaction maps from the 3C data. At the detailed level of individual cells, we will investigate transcription bursts, and how those are involved in the control of circadian gene expression. In particular we will exploit high temporal resolution bioluminescence reporters using a biophysical model of transcription coupled with a Hidden Markov Model (HMM). Through our innovative approach, we expect that the data generated and state-of-the-art analyses performed will lead novel insight into the role and mechanics of circadian transcription in controlling circadian outputs in mammals.
Summary
The aim of this project is to understand the dynamics of protein-DNA interactomes underlying circadian oscillators in mammals, and how these shape circadian transcriptional output programs. Specifically our goal is to solve a fundamental issue in circadian biology: the phase specificity problem underlying circadian gene expression. We have taken a challenging and original multi-disciplinary approach in which molecular biology experiments will be tightly interlinked with computational analyses and biophysical modeling. The approach will generate time resolved protein-DNA interactomes in mouse liver for several key circadian repressors at unprecedented resolution. These experiments will be complemented with chromosome conformation capture (3C) experiments to monitor how looping interactions and 3D genome structure rearrange during the circadian cycle, which will inform on how circadian transcription networks use long-range gene regulatory mechanisms. Novel computational algorithms based on biophysical principles will be developed and implemented to optimally analyze interactome and 3C datasets. For the latter, statistical models from polymer physics will be used to reconstruct the chromatin networks and interaction maps from the 3C data. At the detailed level of individual cells, we will investigate transcription bursts, and how those are involved in the control of circadian gene expression. In particular we will exploit high temporal resolution bioluminescence reporters using a biophysical model of transcription coupled with a Hidden Markov Model (HMM). Through our innovative approach, we expect that the data generated and state-of-the-art analyses performed will lead novel insight into the role and mechanics of circadian transcription in controlling circadian outputs in mammals.
Max ERC Funding
1 500 000 €
Duration
Start date: 2011-03-01, End date: 2016-02-29
Project acronym GEOMETRYCELLCYCLE
Project Geometric control of the cell cycle in the fission yeast
Researcher (PI) Sophie Genevieve Elisabeth Martin Benton
Host Institution (HI) UNIVERSITE DE LAUSANNE
Call Details Starting Grant (StG), LS3, ERC-2010-StG_20091118
Summary Cell cycle progression is monitored by checkpoints that ensure the fidelity of cell division and prevent unrestricted cell proliferation. Checkpoints also serve to couple cell size with division – a mechanism important to adapt to changing environmental conditions.
While most studies on cell size homeostasis have focused on the links between size and biosynthetic activity, we have recently discovered a novel geometry-sensing mechanism by which fission yeast cells couple cell length with entry into mitosis. Conceptually, the system is remarkably simple: it is composed of a signal – the protein kinase Pom1 – forming concentration gradients from the ends of the cells, which inhibits a sensor – the protein kinase Cdr2, itself an activator of mitotic entry – placed at the cell equator. Since Pom1 concentration at the cell middle is higher in short cells than in long cells, this suggests a model where Pom1 inhibits Cdr2 until the cell has reached a sufficient length.
These findings open a conceptually new way of thinking about cell size homeostasis and suggest that cell polarity and cell shape have important effect on cell cycle progression. The proposed project investigates the mechanisms and functional importance of this geometry-sensing system through four specific aims:
Aim 1. Defining and modeling the molecular mechanisms of Pom1 gradient formation
Aim 2. Dissecting the mechanisms of Pom1 action
Aim 3. Investigating the influence of altered cell shape on cell proliferation
Aim 4. Exploring the effect of environmental stresses to the Pom1-Cdr2 system
By combining genetic, biochemical, physical, live-imaging and modeling approaches, this project will provide an integrated understanding of how cell geometry can be perceived at the molecular level and how this information is transduced to control cell proliferation. This work will have wide-ranging implication for our understanding of gradient formation, cell size homeostasis, and the role of cell polarity in proliferation. It will thus be of interest to cell, developmental and cancer biologists alike.
Summary
Cell cycle progression is monitored by checkpoints that ensure the fidelity of cell division and prevent unrestricted cell proliferation. Checkpoints also serve to couple cell size with division – a mechanism important to adapt to changing environmental conditions.
While most studies on cell size homeostasis have focused on the links between size and biosynthetic activity, we have recently discovered a novel geometry-sensing mechanism by which fission yeast cells couple cell length with entry into mitosis. Conceptually, the system is remarkably simple: it is composed of a signal – the protein kinase Pom1 – forming concentration gradients from the ends of the cells, which inhibits a sensor – the protein kinase Cdr2, itself an activator of mitotic entry – placed at the cell equator. Since Pom1 concentration at the cell middle is higher in short cells than in long cells, this suggests a model where Pom1 inhibits Cdr2 until the cell has reached a sufficient length.
These findings open a conceptually new way of thinking about cell size homeostasis and suggest that cell polarity and cell shape have important effect on cell cycle progression. The proposed project investigates the mechanisms and functional importance of this geometry-sensing system through four specific aims:
Aim 1. Defining and modeling the molecular mechanisms of Pom1 gradient formation
Aim 2. Dissecting the mechanisms of Pom1 action
Aim 3. Investigating the influence of altered cell shape on cell proliferation
Aim 4. Exploring the effect of environmental stresses to the Pom1-Cdr2 system
By combining genetic, biochemical, physical, live-imaging and modeling approaches, this project will provide an integrated understanding of how cell geometry can be perceived at the molecular level and how this information is transduced to control cell proliferation. This work will have wide-ranging implication for our understanding of gradient formation, cell size homeostasis, and the role of cell polarity in proliferation. It will thus be of interest to cell, developmental and cancer biologists alike.
Max ERC Funding
1 500 000 €
Duration
Start date: 2010-09-01, End date: 2016-08-31
Project acronym INSIGHT
Project An Integrated Network of Glucose Sensing Cells in Glucose Homeostasis
Researcher (PI) Bernard Marie Thorens
Host Institution (HI) UNIVERSITE DE LAUSANNE
Call Details Advanced Grant (AdG), LS4, ERC-2010-AdG_20100317
Summary Glucose sensing cells constantly monitor glucose absorption from food and variations in blood glycemic levels. They control the secretion of GLP-1, insulin and glucagon, and the activity of the autonomic nervous system. These hormonal and nervous signals coordinate glucose utilization by liver, fat and muscle, and endogenous glucose production as well as feeding and energy expenditure. Type 2 diabetes, a disease that afflicts an increasing proportion of the world population, is characterized by insufficient insulin production by pancreatic beta-cells, abnormal secretion of GLP-1 and glucagon, and is often associated with imbalance between feeding and energy expenditure. Type 2 diabetes can thus be considered a disease of glucose sensing. Here, I propose a research program using cell biological, genetic, genomic and physiology techniques to investigate three aspects of this integrated glucose sensing network:
1. The identification of novel molecular pathways activated by GLP-1 and that control adult beta-cell proliferation, glucose competence and apoptosis in order to maintain sufficient insulin secretion capacity.
2. The identification and molecular characterization of brain glucose sensors, which share functional similarities with pancreatic beta-cells, and which control glucose homeostasis and pancreatic islet mass and function.
3. The discovery by unbiased genetic-genomic analysis of loci, genes, and gene networks involved in central hypoglycemia detection and the secretion of glucagon, a process whose deregulation is a major limitation in insulin treatment of both type 1 and type 2 diabetes.
Together these investigations will bring new knowledge on the integrated control of glucose homeostasis that may lead to novel strategies to control diabetes.
Summary
Glucose sensing cells constantly monitor glucose absorption from food and variations in blood glycemic levels. They control the secretion of GLP-1, insulin and glucagon, and the activity of the autonomic nervous system. These hormonal and nervous signals coordinate glucose utilization by liver, fat and muscle, and endogenous glucose production as well as feeding and energy expenditure. Type 2 diabetes, a disease that afflicts an increasing proportion of the world population, is characterized by insufficient insulin production by pancreatic beta-cells, abnormal secretion of GLP-1 and glucagon, and is often associated with imbalance between feeding and energy expenditure. Type 2 diabetes can thus be considered a disease of glucose sensing. Here, I propose a research program using cell biological, genetic, genomic and physiology techniques to investigate three aspects of this integrated glucose sensing network:
1. The identification of novel molecular pathways activated by GLP-1 and that control adult beta-cell proliferation, glucose competence and apoptosis in order to maintain sufficient insulin secretion capacity.
2. The identification and molecular characterization of brain glucose sensors, which share functional similarities with pancreatic beta-cells, and which control glucose homeostasis and pancreatic islet mass and function.
3. The discovery by unbiased genetic-genomic analysis of loci, genes, and gene networks involved in central hypoglycemia detection and the secretion of glucagon, a process whose deregulation is a major limitation in insulin treatment of both type 1 and type 2 diabetes.
Together these investigations will bring new knowledge on the integrated control of glucose homeostasis that may lead to novel strategies to control diabetes.
Max ERC Funding
2 499 421 €
Duration
Start date: 2011-08-01, End date: 2016-07-31
Project acronym KIDNEY CANCER
Project Molecular mechanisms underlying control of renal epithelial proliferative homeostasis
Researcher (PI) Ian James Frew
Host Institution (HI) UNIVERSITAT ZURICH
Call Details Starting Grant (StG), LS4, ERC-2010-StG_20091118
Summary This research grant has two major aspects. The first seeks to understand the molecular and cellular basis of the evolution of clear cell renal cell carcinoma(ccRCC), the most frequent form of kidney cancer. We will utilise an integrated approach based on mouse genetics, the use of primary kidney epithelial cell culture systems, genetic screening approaches using RNA interference libraries and analysis of the genetic and molecular changes that arise in human kidney tumours. The rationale behind these studies is that by better understanding the molecular causes of ccRCC it will be possible to identify new molecules or signaling pathways that could serve as appropriate therapeutic targets. The second aspect of this grant relates to the development of a flexible experimental platform that will allow the rapid and simultaneous up- and down-regulation of gene expression in the mouse kidney in a manner in which the affected cells are marked by a luminescent marker. This system will be based on the injection of modified lentiviral gene overexpression and gene knockdown vectors, allowing us to exploit recently-developed genome-wide cDNA libraries and RNA interference libraries. This experimental system should be equally applicable to other organ systems and will allow for the first time a systematic approach to the manipulation of gene expression in living mice, additionally bypassing the time limitations associated with conventional mouse genetic approaches. We aim to develop this system within the biological context of this grant and will combine it with live-animal imaging approaches to generate a series of mouse models of ccRCC. These will ultimately serve as invaluable tools for testing novel therapeutic approaches against this currently untreatable disease.
Summary
This research grant has two major aspects. The first seeks to understand the molecular and cellular basis of the evolution of clear cell renal cell carcinoma(ccRCC), the most frequent form of kidney cancer. We will utilise an integrated approach based on mouse genetics, the use of primary kidney epithelial cell culture systems, genetic screening approaches using RNA interference libraries and analysis of the genetic and molecular changes that arise in human kidney tumours. The rationale behind these studies is that by better understanding the molecular causes of ccRCC it will be possible to identify new molecules or signaling pathways that could serve as appropriate therapeutic targets. The second aspect of this grant relates to the development of a flexible experimental platform that will allow the rapid and simultaneous up- and down-regulation of gene expression in the mouse kidney in a manner in which the affected cells are marked by a luminescent marker. This system will be based on the injection of modified lentiviral gene overexpression and gene knockdown vectors, allowing us to exploit recently-developed genome-wide cDNA libraries and RNA interference libraries. This experimental system should be equally applicable to other organ systems and will allow for the first time a systematic approach to the manipulation of gene expression in living mice, additionally bypassing the time limitations associated with conventional mouse genetic approaches. We aim to develop this system within the biological context of this grant and will combine it with live-animal imaging approaches to generate a series of mouse models of ccRCC. These will ultimately serve as invaluable tools for testing novel therapeutic approaches against this currently untreatable disease.
Max ERC Funding
1 500 000 €
Duration
Start date: 2010-12-01, End date: 2015-11-30
Project acronym KRABNKAP
Project KRAB/KAP1-mediated gene regulation in mammalian physiology and human diseases
Researcher (PI) Didier Trono
Host Institution (HI) ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
Call Details Advanced Grant (AdG), LS4, ERC-2010-AdG_20100317
Summary This project aims at exploring the roles or KRAB/KAP1-mediated gene regulation in mammalian physiology and the possible impact of its dysfunctions on human health. The proper control of gene expression is paramount to all biological events, and is orchestrated through a sophisticated balance of activating and repressing influences. The mouse and human genomes contain around four hundred genes encoding KRAB-containing zinc finger proteins (KRAB-ZFPs), a family of tetrapod-restricted sequence-specific DNA-binding transcriptional repressors. Even though these KRAB-ZFPs represent the single largest group of transcriptional regulators encoded by higher vertebrates, their functions remain largely unknown. Nevertheless, it has been established that they share an essential cofactor, the histone methyltransferase- and histone deacetylase-recruiting KAP1, and act by triggering the formation of heterochromatin. KAP1 is ubiquitous, and KRAB-ZFPs are present in most if not all cells, albeit along distinctly cell type-, stage- and state-specific patterns, suggesting that KRAB/KAP1 gene regulation influences a very large number of physiological events. A few years ago, we launched a program aimed at addressing this hypothesis through a combination of genetic, functional and molecular studies focused on two paradigmatic organs, the lympho-hematopoietic system and the liver. Our preliminary results confirm that KRAB/KAP1-mediated transcriptional control is a master regulator of mammalian homeostasis. Accordingly, we now propose to dissect the regulatory networks orchestrated by KAP1 and KRAB-ZFPs in these two systems, to identify their gene targets and the mechanisms of their control, and to probe their possible implication in human pathologies targeting these organs.
Summary
This project aims at exploring the roles or KRAB/KAP1-mediated gene regulation in mammalian physiology and the possible impact of its dysfunctions on human health. The proper control of gene expression is paramount to all biological events, and is orchestrated through a sophisticated balance of activating and repressing influences. The mouse and human genomes contain around four hundred genes encoding KRAB-containing zinc finger proteins (KRAB-ZFPs), a family of tetrapod-restricted sequence-specific DNA-binding transcriptional repressors. Even though these KRAB-ZFPs represent the single largest group of transcriptional regulators encoded by higher vertebrates, their functions remain largely unknown. Nevertheless, it has been established that they share an essential cofactor, the histone methyltransferase- and histone deacetylase-recruiting KAP1, and act by triggering the formation of heterochromatin. KAP1 is ubiquitous, and KRAB-ZFPs are present in most if not all cells, albeit along distinctly cell type-, stage- and state-specific patterns, suggesting that KRAB/KAP1 gene regulation influences a very large number of physiological events. A few years ago, we launched a program aimed at addressing this hypothesis through a combination of genetic, functional and molecular studies focused on two paradigmatic organs, the lympho-hematopoietic system and the liver. Our preliminary results confirm that KRAB/KAP1-mediated transcriptional control is a master regulator of mammalian homeostasis. Accordingly, we now propose to dissect the regulatory networks orchestrated by KAP1 and KRAB-ZFPs in these two systems, to identify their gene targets and the mechanisms of their control, and to probe their possible implication in human pathologies targeting these organs.
Max ERC Funding
2 499 996 €
Duration
Start date: 2011-04-01, End date: 2016-03-31
Project acronym LYVICAM
Project Lymphatic Vessels in Inflammation and Cancer Metastasis
Researcher (PI) Michael Johannes Detmar
Host Institution (HI) EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH
Call Details Advanced Grant (AdG), LS4, ERC-2010-AdG_20100317
Summary Primary cancers can induce lymphatic vessel growth (lymphangiogenesis), enhancing metastasis to draining lymph nodes (LNs). We found that tumors also induce lymphangiogenesis in draining LNs, leading to increased cancer spread to distal LNs and beyond. Very recently, we found that lymphatic vessel activation in peripheral tissues and draining LNs also plays a previously unanticipated role in the control of chronic inflammatory diseases. This proposal aims at a comprehensive characterization of the function of lymphatic vessels in inflammation, using a variety of genetic mouse models for enhanced or reduced lymphatic function, novel quantitative techniques for the in vivo imaging of lymphatic function, and a miniaturized 3-dimensional in vitro platform for the high-throughput phenotypic screening of libraries of small, drug-like molecules for modulators of lymphatic function. A genome-wide analysis of the gene expression profile shall be made from lymphatic vessels isolated by high-speed cell sorting and by immuno-laser capture microdissection from tumors and their lymph node metastases, inflamed tissue and its draining lymph nodes, and normal tissues, followed by functional characterization of potential therapeutic targets and diagnostic markers. Finally, we will establish novel genetically fluorescent mouse models for the in vivo real-time imaging of lymphatic activation, and we will develop an innovative approach for the in vivo detection of early micrometastases, using antibody-based PET and near-infrared imaging of tumor-induced stromal changes. These studies will improve our understanding of lymphatic involvement in inflammation and cancer metastasis, and will provide the basis for completely novel approaches to treat and detect inflammation and cancer metastasis.
Summary
Primary cancers can induce lymphatic vessel growth (lymphangiogenesis), enhancing metastasis to draining lymph nodes (LNs). We found that tumors also induce lymphangiogenesis in draining LNs, leading to increased cancer spread to distal LNs and beyond. Very recently, we found that lymphatic vessel activation in peripheral tissues and draining LNs also plays a previously unanticipated role in the control of chronic inflammatory diseases. This proposal aims at a comprehensive characterization of the function of lymphatic vessels in inflammation, using a variety of genetic mouse models for enhanced or reduced lymphatic function, novel quantitative techniques for the in vivo imaging of lymphatic function, and a miniaturized 3-dimensional in vitro platform for the high-throughput phenotypic screening of libraries of small, drug-like molecules for modulators of lymphatic function. A genome-wide analysis of the gene expression profile shall be made from lymphatic vessels isolated by high-speed cell sorting and by immuno-laser capture microdissection from tumors and their lymph node metastases, inflamed tissue and its draining lymph nodes, and normal tissues, followed by functional characterization of potential therapeutic targets and diagnostic markers. Finally, we will establish novel genetically fluorescent mouse models for the in vivo real-time imaging of lymphatic activation, and we will develop an innovative approach for the in vivo detection of early micrometastases, using antibody-based PET and near-infrared imaging of tumor-induced stromal changes. These studies will improve our understanding of lymphatic involvement in inflammation and cancer metastasis, and will provide the basis for completely novel approaches to treat and detect inflammation and cancer metastasis.
Max ERC Funding
2 493 300 €
Duration
Start date: 2011-05-01, End date: 2016-04-30
Project acronym MICROBIOTAEVOLUTION
Project A phylogenetic and experimental approach to understand the evolution of microbiota
Researcher (PI) Dieter Ebert
Host Institution (HI) UNIVERSITAT BASEL
Call Details Advanced Grant (AdG), LS8, ERC-2010-AdG_20100317
Summary Microbial communities (=microbiota) associated with multicellular organisms play an important role in host nutrition and development. Advances in sequencing technology have revealed an unexpectedly high diversity of microbiota; these advances are not, however, matched by advances in our understanding of the evolutionary factors that structure microbiota. The goal of this proposal is to fill this knowledge gap. Evolutionary models developed for simple host-symbiont relationships have identified a number of factors that shape these relationships: mode of transmission (horizontal versus maternal transmission), host ranges and fitness effects for the host. Together these factors influence the role of selection among hosts and the role of selection within hosts (among microbes), the two levels of selection that are believed to shape host-symbiont coevolution. Here I intend to expand these models to host - microbiota interactions.
My objectives are to use next-generation sequencing to conduct a comparative study of bacterial microbiota structure and to combine this work with experiments that explore the underlying evolutionary processes. I will focus on the crustacean family Daphniidae (mainly the genus Daphnia)¿a system ideally suited for studies in the field and laboratory. I will test hypotheses about the evolution of mutualism, virulence, cheating and coevolution, as well as test for the role of mode of transmission and host specificity. The analysis of host-microbiota associations will be conducted for entire microbiota and for stepwise simplified, but biologically meaningful subsets.
Testing general models for the evolution of microbiota will have implications far beyond the chosen model system, ranging from ecology and evolution to agricultural sciences and medicine. The proposed study is innovative, significant and risk-taking and will combine skills in evolutionary biology, experimental design, bioinformatics and molecular biology.
Summary
Microbial communities (=microbiota) associated with multicellular organisms play an important role in host nutrition and development. Advances in sequencing technology have revealed an unexpectedly high diversity of microbiota; these advances are not, however, matched by advances in our understanding of the evolutionary factors that structure microbiota. The goal of this proposal is to fill this knowledge gap. Evolutionary models developed for simple host-symbiont relationships have identified a number of factors that shape these relationships: mode of transmission (horizontal versus maternal transmission), host ranges and fitness effects for the host. Together these factors influence the role of selection among hosts and the role of selection within hosts (among microbes), the two levels of selection that are believed to shape host-symbiont coevolution. Here I intend to expand these models to host - microbiota interactions.
My objectives are to use next-generation sequencing to conduct a comparative study of bacterial microbiota structure and to combine this work with experiments that explore the underlying evolutionary processes. I will focus on the crustacean family Daphniidae (mainly the genus Daphnia)¿a system ideally suited for studies in the field and laboratory. I will test hypotheses about the evolution of mutualism, virulence, cheating and coevolution, as well as test for the role of mode of transmission and host specificity. The analysis of host-microbiota associations will be conducted for entire microbiota and for stepwise simplified, but biologically meaningful subsets.
Testing general models for the evolution of microbiota will have implications far beyond the chosen model system, ranging from ecology and evolution to agricultural sciences and medicine. The proposed study is innovative, significant and risk-taking and will combine skills in evolutionary biology, experimental design, bioinformatics and molecular biology.
Max ERC Funding
2 446 004 €
Duration
Start date: 2011-06-01, End date: 2016-05-31
Project acronym MULTIRULES
Project Synaptic multi-factor learning rules: from action potentials to behaviour
Researcher (PI) Wulfram Gerstner
Host Institution (HI) ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
Call Details Advanced Grant (AdG), LS5, ERC-2010-AdG_20100317
Summary If we are ever to unravel the mysteries of learning, we need a strong theoretical framework that will enable us to trace behavioural properties of memory formation and action learning back to rules for changes of synaptic connections. Experiments on the cell and microcircuit level need hypothesis from theory in order to drive the experimental search for plasticity rules and organize the vast amount of data collected in different labs across Europe and the world. Potential links between synaptic plasticity rules and behavioural outcomes need to be established by mathematical analysis and computer simulation on the systems level, and could ultimately also lead to novel therapeutical approaches.
Both theoretical and experimental approaches to synaptic plasticity have been dominated, in the past 30 years, by Hebb¿s rule but the Hebbian framework is a limitation, because it focuses only on two factors: the activity of the presynaptic (sending) neuron and that of the postsynaptic (receiving) one. Hence it neglects additional factors, such as non-specific neuromodulators or global activity states of brain areas. Only very recently a few experiments have appeared that study STDP in the presence of neuromodulators.
In this project, I want to break with the preoccupation of Hebbian rules, and formulate and study rules of synaptic plasticity that combine the two Hebbian activity factors with one or multiple global factors. With the new theoretical framework for multi-factor learning rules, to be developed in this project, I will be able to guide the design of novel experiments so that experimental paradigms probe parameters that are relevant for learning. I will be able to make predictions for functional outcomes of learning on the behavioural level, and possibly provide novel strategies for learning of new memories, or unlearning of unpleasant ones.
Summary
If we are ever to unravel the mysteries of learning, we need a strong theoretical framework that will enable us to trace behavioural properties of memory formation and action learning back to rules for changes of synaptic connections. Experiments on the cell and microcircuit level need hypothesis from theory in order to drive the experimental search for plasticity rules and organize the vast amount of data collected in different labs across Europe and the world. Potential links between synaptic plasticity rules and behavioural outcomes need to be established by mathematical analysis and computer simulation on the systems level, and could ultimately also lead to novel therapeutical approaches.
Both theoretical and experimental approaches to synaptic plasticity have been dominated, in the past 30 years, by Hebb¿s rule but the Hebbian framework is a limitation, because it focuses only on two factors: the activity of the presynaptic (sending) neuron and that of the postsynaptic (receiving) one. Hence it neglects additional factors, such as non-specific neuromodulators or global activity states of brain areas. Only very recently a few experiments have appeared that study STDP in the presence of neuromodulators.
In this project, I want to break with the preoccupation of Hebbian rules, and formulate and study rules of synaptic plasticity that combine the two Hebbian activity factors with one or multiple global factors. With the new theoretical framework for multi-factor learning rules, to be developed in this project, I will be able to guide the design of novel experiments so that experimental paradigms probe parameters that are relevant for learning. I will be able to make predictions for functional outcomes of learning on the behavioural level, and possibly provide novel strategies for learning of new memories, or unlearning of unpleasant ones.
Max ERC Funding
2 449 218 €
Duration
Start date: 2011-05-01, End date: 2016-04-30
Project acronym PBDR
Project The population biology of drug resistance:
Key principles for a more sustainable use of drugs
Researcher (PI) Lukas Sebastian Bonhoeffer
Host Institution (HI) EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH
Call Details Advanced Grant (AdG), LS8, ERC-2010-AdG_20100317
Summary The evolution of drug resistance and its control represents a considerable challenge in very different biological contexts ranging from pesticide resistance in agriculture to antimicrobial resistance in clinical settings and even extends beyond infectious pathogens, as resistance also evolves in cancer chemotherapy. Naturally, the recommendations for the optimal use of drugs to minimise resistance differ for different biological contexts. In some cases, similar strategies for vastly different pathogens or biological contexts are recommended, whereas in other cases opposing strategies for similar pathogens are advised. To which extent these discrepancies in treatment recommendations are attributable to specific properties of the pathogen, the host, or the general biological context is currently unclear. The aim of this proposal is to develop an integrative population biological framework for the evolution of resistance and its control. To this end we will develop mathematical models of resistance evolution in viruses, bacteria, parasites, cancer and fungal plant pathogens. Developing detailed population biological models that account for the specific biology of these ¿pathogens¿ as well as the specific context of the application of drugs will allow us to identify those aspects that are common between different biological contexts and those aspects that are specific to the pathogen, the host or the drug. Moreover, working simultaneously on resistance evolution in these different biological contexts will facilitate the translation of findings between fields of research that to date have remained largely separate. We seek to bridge these fields and integrate insight to develop a broad conceptual framework with which to address the ever-growing problem of sustainable drug use.
Summary
The evolution of drug resistance and its control represents a considerable challenge in very different biological contexts ranging from pesticide resistance in agriculture to antimicrobial resistance in clinical settings and even extends beyond infectious pathogens, as resistance also evolves in cancer chemotherapy. Naturally, the recommendations for the optimal use of drugs to minimise resistance differ for different biological contexts. In some cases, similar strategies for vastly different pathogens or biological contexts are recommended, whereas in other cases opposing strategies for similar pathogens are advised. To which extent these discrepancies in treatment recommendations are attributable to specific properties of the pathogen, the host, or the general biological context is currently unclear. The aim of this proposal is to develop an integrative population biological framework for the evolution of resistance and its control. To this end we will develop mathematical models of resistance evolution in viruses, bacteria, parasites, cancer and fungal plant pathogens. Developing detailed population biological models that account for the specific biology of these ¿pathogens¿ as well as the specific context of the application of drugs will allow us to identify those aspects that are common between different biological contexts and those aspects that are specific to the pathogen, the host or the drug. Moreover, working simultaneously on resistance evolution in these different biological contexts will facilitate the translation of findings between fields of research that to date have remained largely separate. We seek to bridge these fields and integrate insight to develop a broad conceptual framework with which to address the ever-growing problem of sustainable drug use.
Max ERC Funding
2 272 403 €
Duration
Start date: 2011-07-01, End date: 2017-06-30
Project acronym PICS THERAPY
Project Manipulation of senescence pathways for cancer therapy: from experimental models to clinic
Researcher (PI) Andrea Alimonti
Host Institution (HI) Ente Ospedaliero Cantonale
Call Details Starting Grant (StG), LS7, ERC-2010-StG_20091118
Summary This proposal aims to harness a novel type of senescence that we have identified in response to acute Pten inactivation, and which we believe offers a radical therapeutic approach to target the quiescent cancer stem cell in vivo. In characterizing Pten loss Induced Cellular Senescence, which we have named PICS for short, we have discovered that PICS is distinct from other forms of cellular senescence including oncogene-induced senescence (OIS) and replicative senescence. These distinct differences are characterized by a lack of DNA damage and hyper-replication, breaking the current dogma for senescence induction. The ability to induce senescence, an irreversible growth arrest, in cells by targeting Pten signaling, without a requirement for hyper-replication and DNA damage opens up the possibility to target quiescent cells, including stem cells, that have a low proliferative index. This approach has tremendous therapeutic potential and represents one of the most exciting developments for the advancement of prostate cancer therapy in recent years. Through the manipulation of senescence induction pathways we will identify PICS enhancing drugs and redefine the paradigm for cancer therapy. By developing novel mouse models that target prostate stem cells we will evaluate these PICS pro-senescence drugs in a pre-clinical setting. Finally, these results will be cross referenced with data from human prostate stem cells and we will lay the ground work to translate this to the clinical setting, further developing the clinical potential of these findings to eradicate prostate cancer.
Summary
This proposal aims to harness a novel type of senescence that we have identified in response to acute Pten inactivation, and which we believe offers a radical therapeutic approach to target the quiescent cancer stem cell in vivo. In characterizing Pten loss Induced Cellular Senescence, which we have named PICS for short, we have discovered that PICS is distinct from other forms of cellular senescence including oncogene-induced senescence (OIS) and replicative senescence. These distinct differences are characterized by a lack of DNA damage and hyper-replication, breaking the current dogma for senescence induction. The ability to induce senescence, an irreversible growth arrest, in cells by targeting Pten signaling, without a requirement for hyper-replication and DNA damage opens up the possibility to target quiescent cells, including stem cells, that have a low proliferative index. This approach has tremendous therapeutic potential and represents one of the most exciting developments for the advancement of prostate cancer therapy in recent years. Through the manipulation of senescence induction pathways we will identify PICS enhancing drugs and redefine the paradigm for cancer therapy. By developing novel mouse models that target prostate stem cells we will evaluate these PICS pro-senescence drugs in a pre-clinical setting. Finally, these results will be cross referenced with data from human prostate stem cells and we will lay the ground work to translate this to the clinical setting, further developing the clinical potential of these findings to eradicate prostate cancer.
Max ERC Funding
1 500 000 €
Duration
Start date: 2011-04-01, End date: 2016-03-31
Project acronym POPRNASEQ
Project Population transcriptional genomics in humans using high throughput sequencing
Researcher (PI) Emmanouil Dermitzakis
Host Institution (HI) UNIVERSITE DE GENEVE
Call Details Starting Grant (StG), LS2, ERC-2010-StG_20091118
Summary Gene expression is one of the marks of cellular state and function. The relative abundance of transcripts defines and is a result of the differentiation status of a cell. Interrogation of gene expression levels and patterns in the human and other genomes can be informative about perturbations from the average pattern due to external stimuli or internal factors such as genetic variants. Gene expression profiles have been extensively used to assess developmental processes, pathways contributing to cell differentiation, and predicting the outcome of disease status.
Understanding the effects of genetic variation in basic cellular processes such as gene expression is key to the dissection of the genetic contributions to whole organism phenotypes.
We propose to interrogate the transcriptome of primary fibroblasts, primary T-cells and EBV-transformed B-cell (lymphoblastoid cell lines or LCLs) from umbilical cords of 200 individuals of European descent using next generation sequencing (mRNAseq). A subset will also be interrogated for transcriptionally engaged RNA polymerases (GROseq) and protein abundance. These data will be analyzed for the detection of eQTLs and other genetic effects associated with variation in alternative splicing and other properties of the transcripts and dissection of the genetic effects from primary transcription to protein and their tissue specific effects. These data will be integrated with genome-wide association studies and other efforts to dissect the genetic basis of complex traits and diseases in humans. In addition, we will develop bioinformatic models to understand the fine scale regulatory signals that are responsible for the regulatory patterns observed and how sequence variants have an effect on them.
Summary
Gene expression is one of the marks of cellular state and function. The relative abundance of transcripts defines and is a result of the differentiation status of a cell. Interrogation of gene expression levels and patterns in the human and other genomes can be informative about perturbations from the average pattern due to external stimuli or internal factors such as genetic variants. Gene expression profiles have been extensively used to assess developmental processes, pathways contributing to cell differentiation, and predicting the outcome of disease status.
Understanding the effects of genetic variation in basic cellular processes such as gene expression is key to the dissection of the genetic contributions to whole organism phenotypes.
We propose to interrogate the transcriptome of primary fibroblasts, primary T-cells and EBV-transformed B-cell (lymphoblastoid cell lines or LCLs) from umbilical cords of 200 individuals of European descent using next generation sequencing (mRNAseq). A subset will also be interrogated for transcriptionally engaged RNA polymerases (GROseq) and protein abundance. These data will be analyzed for the detection of eQTLs and other genetic effects associated with variation in alternative splicing and other properties of the transcripts and dissection of the genetic effects from primary transcription to protein and their tissue specific effects. These data will be integrated with genome-wide association studies and other efforts to dissect the genetic basis of complex traits and diseases in humans. In addition, we will develop bioinformatic models to understand the fine scale regulatory signals that are responsible for the regulatory patterns observed and how sequence variants have an effect on them.
Max ERC Funding
1 500 000 €
Duration
Start date: 2011-05-01, End date: 2016-04-30
Project acronym RESIST
Project Resistance systems and population structure of parasites
Researcher (PI) Paul Hermann Schmid
Host Institution (HI) EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH
Call Details Advanced Grant (AdG), LS8, ERC-2010-AdG_20100317
Summary The study of parasitism is important for human welfare but also addresses basic scientific questions cutting across biological disciplines. Traditionally, studies of host-parasite interactions have used various scenarios of how genotypes of the two parties interact based on well-developed theory. Yet, one of the most striking observations is the huge variation in resistance systems across organisms. We lack an appreciation of the diversity of these resistance systems and how they affect, in turn, the parasites. Here, it is proposed to investigate the hypothesis that variation in gene expression is a key element that defines an alternative, flexible and highly adaptable resistance system. The project attempts to unify genomic studies of defence mechanisms with questions of evolutionary ecology of host-parasite interactions. Therefore, the study focuses on an ecologically well-studied system of hosts (Bombus spp.) and their prevalent trypanosome infections (Crithidia). In this system, a highly genetically polymorphic parasite is kept in check by a host with seemingly conserved immune effectors (e.g. anti-microbial peptides, AMPs). Their expression varies depending on the host-parasite pairing, suggesting that variation of the synergistic mixture of expressed defence elements might be crucial and could affect parasite population structure in turn. In the project, experiments and cutting-edge molecular methods will be applied to a natural host-parasite system.
Summary
The study of parasitism is important for human welfare but also addresses basic scientific questions cutting across biological disciplines. Traditionally, studies of host-parasite interactions have used various scenarios of how genotypes of the two parties interact based on well-developed theory. Yet, one of the most striking observations is the huge variation in resistance systems across organisms. We lack an appreciation of the diversity of these resistance systems and how they affect, in turn, the parasites. Here, it is proposed to investigate the hypothesis that variation in gene expression is a key element that defines an alternative, flexible and highly adaptable resistance system. The project attempts to unify genomic studies of defence mechanisms with questions of evolutionary ecology of host-parasite interactions. Therefore, the study focuses on an ecologically well-studied system of hosts (Bombus spp.) and their prevalent trypanosome infections (Crithidia). In this system, a highly genetically polymorphic parasite is kept in check by a host with seemingly conserved immune effectors (e.g. anti-microbial peptides, AMPs). Their expression varies depending on the host-parasite pairing, suggesting that variation of the synergistic mixture of expressed defence elements might be crucial and could affect parasite population structure in turn. In the project, experiments and cutting-edge molecular methods will be applied to a natural host-parasite system.
Max ERC Funding
2 100 000 €
Duration
Start date: 2011-05-01, End date: 2016-04-30
Project acronym RUBINET
Project Regulation of cell growth and division by selective degradation mechanisms
Researcher (PI) Matthias Peter
Host Institution (HI) EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH
Call Details Advanced Grant (AdG), LS3, ERC-2010-AdG_20100317
Summary Cell growth and division are tightly regulated by phosphorylation and selective degradation of cellular components. Whereas autophagy is mainly responsible to eliminate long-lived proteins and organelles, the ubiquitin-proteasome system (UPS) rapidly degrades proteins when fast adaptation is needed. Defects in these degradation systems accounts for numerous human diseases, including cancer, muscle dystrophies, viral and bacterial infections and neurodegeneration. While rapid progress has been made in the identification of UPS and autophagy components, little is known about their regulation and the molecular mechanisms that ensure substrate specificity. We therefore propose an interdisciplinary combination of biochemistry, cell and structural biology, genetics, RNAi-screening, quantitative microscopy and microfluidic technology to tackle these questions in yeast and mammalian cells.
E3 ubiquitin ligase complexes are important UPS components that specifically bind substrates via dedicated adaptors. In particular, cullin-based E3-ligases control cell growth and division, but much needs to be learned about their regulation and the identity and function of their key substrates. Moreover, we uncovered a function of RING-H2 E3-ligases in MAP-kinase networks, providing a new link between phosphorylation and the UPS. Finally, while autophagy can selectively remove protein aggregates and damaged or excess organelles, the underlying mechanisms that provide specificity to this process are poorly understood. Recent evidence suggests that ubiquitin may also serve as a recognition signal for selective autophagy. We will thus investigate the roles of ubiquitin and specific autophagy substrate-adaptors, and focus on the molecular crosstalk between selective autophagy and the UPS.
Summary
Cell growth and division are tightly regulated by phosphorylation and selective degradation of cellular components. Whereas autophagy is mainly responsible to eliminate long-lived proteins and organelles, the ubiquitin-proteasome system (UPS) rapidly degrades proteins when fast adaptation is needed. Defects in these degradation systems accounts for numerous human diseases, including cancer, muscle dystrophies, viral and bacterial infections and neurodegeneration. While rapid progress has been made in the identification of UPS and autophagy components, little is known about their regulation and the molecular mechanisms that ensure substrate specificity. We therefore propose an interdisciplinary combination of biochemistry, cell and structural biology, genetics, RNAi-screening, quantitative microscopy and microfluidic technology to tackle these questions in yeast and mammalian cells.
E3 ubiquitin ligase complexes are important UPS components that specifically bind substrates via dedicated adaptors. In particular, cullin-based E3-ligases control cell growth and division, but much needs to be learned about their regulation and the identity and function of their key substrates. Moreover, we uncovered a function of RING-H2 E3-ligases in MAP-kinase networks, providing a new link between phosphorylation and the UPS. Finally, while autophagy can selectively remove protein aggregates and damaged or excess organelles, the underlying mechanisms that provide specificity to this process are poorly understood. Recent evidence suggests that ubiquitin may also serve as a recognition signal for selective autophagy. We will thus investigate the roles of ubiquitin and specific autophagy substrate-adaptors, and focus on the molecular crosstalk between selective autophagy and the UPS.
Max ERC Funding
2 426 976 €
Duration
Start date: 2011-05-01, End date: 2016-04-30
Project acronym VOTECOM
Project Vocal template computations in the songbird brain
Researcher (PI) Richard Hans Robert Hahnloser
Host Institution (HI) UNIVERSITAT ZURICH
Call Details Advanced Grant (AdG), LS5, ERC-2010-AdG_20100317
Summary Song learning in oscine birds shares several characteristics with human language learning: it relies on social interaction, active participation, and error feedback, and must take place within a critical period. Songbirds learn their songs from a tutor: they memorize a template of tutor song and compare their own song to that template until a good match is achieved. The existence of a song template in the songbird brain has been clearly demonstrated in deafening, isolation, and lesion experiments, and therefore the songbird is one of the best animal models for unravelling neural principles of template-based vocal learning.
Currently we know very little about neural mechanisms in the brain that support template-based learning. In songbirds, our knowledge about the template is limited to behavioural aspects that favour or hinder faithful imitation and to evidence about the brain areas in which the template is stored. Elusive about the template remains its neural representation, as well as the manner in which it is used for evaluating the plastic juvenile songs. Here we propose for the first time a set of experiments aimed at identifying neural mechanisms of template computations including template storage, template recall, and template-based evaluation of auditory feedback.
We test the hypothesis that during singing, juvenile birds recall a memory of tutor song and use that memory to analyze and evaluate their own songs. In the zebra finch, our goal is to find a neural correlate of this memory trace in higher auditory association areas. We believe that our studies will provide fundamental insights into how the brain monitors its behavioral output and compares it to some desired output, for which a sensory template has been memorized.
Summary
Song learning in oscine birds shares several characteristics with human language learning: it relies on social interaction, active participation, and error feedback, and must take place within a critical period. Songbirds learn their songs from a tutor: they memorize a template of tutor song and compare their own song to that template until a good match is achieved. The existence of a song template in the songbird brain has been clearly demonstrated in deafening, isolation, and lesion experiments, and therefore the songbird is one of the best animal models for unravelling neural principles of template-based vocal learning.
Currently we know very little about neural mechanisms in the brain that support template-based learning. In songbirds, our knowledge about the template is limited to behavioural aspects that favour or hinder faithful imitation and to evidence about the brain areas in which the template is stored. Elusive about the template remains its neural representation, as well as the manner in which it is used for evaluating the plastic juvenile songs. Here we propose for the first time a set of experiments aimed at identifying neural mechanisms of template computations including template storage, template recall, and template-based evaluation of auditory feedback.
We test the hypothesis that during singing, juvenile birds recall a memory of tutor song and use that memory to analyze and evaluate their own songs. In the zebra finch, our goal is to find a neural correlate of this memory trace in higher auditory association areas. We believe that our studies will provide fundamental insights into how the brain monitors its behavioral output and compares it to some desired output, for which a sensory template has been memorized.
Max ERC Funding
2 011 440 €
Duration
Start date: 2011-06-01, End date: 2016-11-30
Project acronym WALK AGAIN
Project Multi-pronged Strategies to Regain Voluntary Motor Functions after Spinal Cord Injury
Researcher (PI) Grégoire Richard Courtine
Host Institution (HI) ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
Call Details Starting Grant (StG), LS5, ERC-2010-StG_20091118
Summary Severe spinal cord injury (SCI) permanently abolishes motor functions caudal to the lesion. Various strategies have been
pursued to promote functional recovery after such injuries. However, none of these attempts were able to return voluntary
movements in paralyzed subjects. Here, we propose an innovative transdisciplinary research program including parallel
approaches that will converge into an integrated multi-pronged therapy able to restore voluntary movements after paralyzing
SCI. To achieve this goal, we will capitalize on our recent breakthroughs that demonstrate the impressive capacity of
pharmacological and electrical spinal cord stimulations to promote full weight bearing walking in paralyzed rats when
combined with rehabilitation. In Walk Again, we will improve high level control of spinal circuits with synergistic combinations
of pharmacological agents, and with the design of multisite stimulation strategies using electrode arrays. Functional electrical
stimulation of muscles will provide complementary low level tuning capacities to adjust limb motion. To allow voluntary control,
we will establish a new line of research and pioneer brain-spinal interfaces by which cortical modulations will directly adjust
stimulations of spinal circuits and muscles. In the final stages, we will enable neurorehabilitation with this cortico-spinal
neuroprosthesis in the presence of anti-NogoA regenerative therapy. The underlying objective is to devise a fully-operative
neuroprosthetic system that will enable self-driven rehabilitation in a permissive plastic environment. Walk Again will fertilize
frontier research with pioneer ideas that will increase European competitiveness while paving the way toward viable clinical
applications to restore function in paralyzed individuals.
Summary
Severe spinal cord injury (SCI) permanently abolishes motor functions caudal to the lesion. Various strategies have been
pursued to promote functional recovery after such injuries. However, none of these attempts were able to return voluntary
movements in paralyzed subjects. Here, we propose an innovative transdisciplinary research program including parallel
approaches that will converge into an integrated multi-pronged therapy able to restore voluntary movements after paralyzing
SCI. To achieve this goal, we will capitalize on our recent breakthroughs that demonstrate the impressive capacity of
pharmacological and electrical spinal cord stimulations to promote full weight bearing walking in paralyzed rats when
combined with rehabilitation. In Walk Again, we will improve high level control of spinal circuits with synergistic combinations
of pharmacological agents, and with the design of multisite stimulation strategies using electrode arrays. Functional electrical
stimulation of muscles will provide complementary low level tuning capacities to adjust limb motion. To allow voluntary control,
we will establish a new line of research and pioneer brain-spinal interfaces by which cortical modulations will directly adjust
stimulations of spinal circuits and muscles. In the final stages, we will enable neurorehabilitation with this cortico-spinal
neuroprosthesis in the presence of anti-NogoA regenerative therapy. The underlying objective is to devise a fully-operative
neuroprosthetic system that will enable self-driven rehabilitation in a permissive plastic environment. Walk Again will fertilize
frontier research with pioneer ideas that will increase European competitiveness while paving the way toward viable clinical
applications to restore function in paralyzed individuals.
Max ERC Funding
1 395 540 €
Duration
Start date: 2010-12-01, End date: 2015-11-30
Project acronym WEBOFLIFE
Project Robustness of The Web of Life in the Face of Global Change
Researcher (PI) Jordi Bascompte Sacrest
Host Institution (HI) UNIVERSITAT ZURICH
Call Details Advanced Grant (AdG), LS8, ERC-2010-AdG_20100317
Summary Recent work on complex networks has provided a theoretical framework to unravel the structure of the Web of Life. Yet, we still know little on the implications of network architecture for the robustness of beneficial network services such as pollination of crop plants. In this proposal, I intend to move beyond current studies of global environmental change that have mainly focused on its consequences for the abundance, phenology, and geographic distributions of independent species, to embrace effects for the network of interactions among species. My strategy to tackle this overall goal is through a synthetic and interdisciplinary approach that combines theory, meta-analysis, and experiment. First, I will integrate a large dataset of ecological networks with phylogenies and life-history traits to simulate the rate and shape of loss of functional groups. Second, I will set up an experimental design to address how two important ecosystem services, pollination and control of insect pests, decline with network disassembly. Third, I will explore early-warning signals of network collapse that may predict the proximity of a critical threshold in the driving forces of global change. My approach can provide a starting point for assessing the community-wide consequences of the current biodiversity crisis.
Summary
Recent work on complex networks has provided a theoretical framework to unravel the structure of the Web of Life. Yet, we still know little on the implications of network architecture for the robustness of beneficial network services such as pollination of crop plants. In this proposal, I intend to move beyond current studies of global environmental change that have mainly focused on its consequences for the abundance, phenology, and geographic distributions of independent species, to embrace effects for the network of interactions among species. My strategy to tackle this overall goal is through a synthetic and interdisciplinary approach that combines theory, meta-analysis, and experiment. First, I will integrate a large dataset of ecological networks with phylogenies and life-history traits to simulate the rate and shape of loss of functional groups. Second, I will set up an experimental design to address how two important ecosystem services, pollination and control of insect pests, decline with network disassembly. Third, I will explore early-warning signals of network collapse that may predict the proximity of a critical threshold in the driving forces of global change. My approach can provide a starting point for assessing the community-wide consequences of the current biodiversity crisis.
Max ERC Funding
1 700 000 €
Duration
Start date: 2011-05-01, End date: 2017-04-30